
Jiaoti Huang MD PhD
Genitourinary Pathology, Obstetrics & Perinatal Pathology, Anatomic Pathology, Surgical Pathology
Professor and Chairman, Department of Pathology, Duke University School of Medicine
Join to View Full Profile
10833 Le Conte AveB186Los Angeles, CA 90095
Phone+1 310-794-1355
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an academic surgical pathologist. My goal is to improve human health through patient care of the highest quality, as well as performing laboratory research and educating physicians of the next generation
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1999 - 2000
- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- CUNY School of MedicinePhD, Molecular and Cellular Biology, 1987 - 1991
- Institute of Radiation MedicineMS, 1983 - 1986
- Anhui Medical UniversityClass of 1983
Certifications & Licensure
- CA State Medical License 2008 - 2026
- NC State Medical License 2015 - 2026
- NY State Medical License 1998 - 2010
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Roberta Nieberg Faculty Teaching Award UCLA Pathology and Laboratory Medicine, 2008
- Eric A. Schenk Award for Excellence in Pathology Education University of Rochester Medical Center, 2006
- Scientific Exchange Award Leukemia Society of America, 1993
- Join now to see all
Publications & Presentations
PubMed
- Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone.Chun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, Yi Wei, Alexandra Lapat Polasko
Clinical Cancer Research. 2025-04-01 - Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostat...Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele, Matthew Rettig, Elisabeth I Heath
Journal of Clinical Oncology. 2025-03-26 - 1 citationsFramework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.Michael C Haffner, Michael J Morris, Chien-Kuang C Ding, Erolcan Sayar, Rohit Mehra
Clinical Cancer Research. 2025-02-03
Journal Articles
- Reprogramming Normal Human Epithelial Tissues to a Common, Lethal Neuroendocrine Cancer LineageJiaoti Huang, John K Lee, Kim Nguyen, Science Magazine
- SRRM4 Gene Expression Correlates with Neuroendocrine Prostate CancerJiaoti Huang, MD, The Prostate
- Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision MakingAriel A Schulman, Jiaoti Huang, Thomas J Polascik, Jamie N Holtz, ScienceDirect
- Join now to see all
Press Mentions
- MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate CancerAugust 26th, 2024
- Closing in on New Treatments for Prostate CancerFebruary 17th, 2023
- Tech Advances Are Enabling Faster, More Accurate Pathological Assessments of CancerApril 10th, 2022
- Join now to see all
Grant Support
- The role of focal adhesion kinase in therapy resistant prostate tumorsDUKE UNIVERSITY2023–2028
- Glutaminase I isoforms as personalized biomarkers of prostate cancerDUKE UNIVERSITY2022–2026
- Glutaminase I isoforms as personalized biomarkers of prostate cancerDUKE UNIVERSITY2022–2026
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: